UBS Group
BHVN

UBS Group’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

UBS Group’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-15,200
Closed -$1.3M – 9992
2020
Q4 		$1.3M Buy
15,200
+1,600
+12% +$136K ﹤0.01% 3800
2020
Q3 		$884K Buy
+13,600
New +$891K ﹤0.01% 3731

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

UBS Group's BHVN Position: Q4 2022 in Review

UBS Group sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 833,464 shares — an estimated $126M sold.

UBS Group first reported a position in BHVN in Q3 2017 and held it in 21 quarters. The position peaked at $126M in Q3 2022. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • UBS Group reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • UBS Group sold 833,464 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $126M.
  • UBS Group first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q3 2017 and held it in 21 quarters.
  • UBS Group's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $126M in Q3 2022.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.